Cannabix Technologies Develops Version 3.0 of THC Breath Analyzer Device
Cannabix is developing the Cannabix Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety...
Staff
Coherus Management to Present at Upcoming Investor Conferences
REDWOOD CITY, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), announced today that senior management...
Entera Bio Announces Publication of Phase 2 Hypoparathyroidism Study in the Journal of Bone and Mineral Research
‒ EB612 When Added to Standard of Care Led to a Statistically Significant Decrease in Supplemental Calcium Usage – ‒ Oral...
NextGen Healthcare to Host Virtual Investor Event
ATLANTA--(BUSINESS WIRE)--$NXGN #AmbulatoryHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, will host a virtual Investor event...
BrainChip Inc. and NaNose Medical Successfully Detect COVID-19 in Exhaled Breath with Fast High-Accuracy Results
Akida AI chip ideal for hand-held diagnostic testing device ALISO VIEJO, Calif.--(BUSINESS WIRE)--BrainChip Holdings Ltd (ASX:BRN), a leading provider of...
AWS Announces General Availability of Amazon Lookout for Vision
Amazon Lookout for Vision uses AWS-trained computer vision models on images and video streams to find anomalies and flaws in...
Vapotherm Reports Fourth Quarter and Fiscal Year 2020 Financial Results
2020 Revenue of $125.7 Million Reflects 161.4% Increase Over Prior Year Results in Line with Preliminary Revenue of $125.4 Million...
GigCapital Global Sponsored SPAC GigCapital2 Reminds Stockholders to Vote in Favor of Extension to June 10, 2021
Special Meeting of Stockholders to Approve Extension Amendment to be held on Monday, March 8, 2021 PALO ALTO, Calif.--(BUSINESS WIRE)--GigCapital2,...
Inogen Announces Fourth Quarter 2020 Financial Results
– Q4 2020 Total Revenue of $74.0 million – – Q4 2020 Rental Revenue of $9.4 million, up 71.7% from...
Carlucci to Hospital Administrators: Buyers Beware on Quality Control Management Systems
NEW YORK, NY / ACCESSWIRE / February 24, 2021 / Former New York State Senator David Carlucci is warning hospital...
Dynatronics Corporation Announces Extension of Key Distribution Agreement
Bird & Cronin Renews Group Purchasing Agreement with Intalere for Orthopedic Soft Goods and Bracing EAGAN, MN / ACCESSWIRE /...
Chemesis International Inc. to Trade in $CAD on the Canadian Securities Exchange
VANCOUVER, BC / ACCESSWIRE / February 24, 2021 / Chemesis International Inc. (the "Company") (CSE:CSI.U)(OTC PINK:CADMF)(FRA:CWAB) is pleased to announce...
Redox Raises $45M in Series D to Drive the Adoption of Technology in Healthcare
Record Number of Health Systems and Digital Health Software Vendors Exchange Data with Redox’s Network Approach MADISON, Wis.--(BUSINESS WIRE)--#EHR--Redox, the...
Aytu BioScience to Present at Upcoming March Investor Conferences
ENGLEWOOD, CO / ACCESSWIRE / February 24, 2021 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing...
Health Canada Authorizes Sparta COVID-19 Safety System’s Antibody and Antigen Rapid-Tests
TORONTO, ON / ACCCESSWIRE / February 24, 2021 / Sparta Group (TSXV:SAY) (the "Corporation" the "Company", "Sparta Group", "Sparta Capital",...
How Advancements in Technology is Spurring Growth of Eye-Tracking System Market: Future Market Insights Report Analyzes
Market players are focusing on capacity expansion to attain a competitive edge DUBAI, UAE / ACCESSWIRE / February 24, 2021...
CoImmune, Inc. Announces Appointment of Ed Baracchini to Board of Directors
DURHAM, N.C., Feb. 24, 2021 (GLOBE NEWSWIRE) -- CoImmune, Inc., a clinical stage immuno-oncology company developing cell-based therapeutics to treat...
Medexus Schedules Third Quarter Fiscal 2021 Conference Call
TORONTO and CHICAGO and MONTREAL, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP)...
Locus Biosciences completes first-of-its-kind controlled clinical trial for CRISPR-enhanced bacteriophage therapy
Phase 1b trial demonstrates that the company’s lead precision medicine asset is safe and well toleratedRESEARCH TRIANGLE PARK, N.C., Feb....
Syneos Health and Protocol First Partner to Accelerate Collection and Review of Clinical Trial Data
Strategic Partnership Optimizes Integration for EHR Data and Delivers Remote Source Data ReviewMORRISVILLE, N.C. and SALT LAKE CITY, Feb. 24,...